Latest News

(UroToday.com) In this talk, Dr. Albiges focused on novel therapeutics on the horizon in advanced renal cell carcinoma (aRCC). She focused first on how a deeper understanding of this disease has nominated targets for novel therapeutics. Dr. Albiges first discussed the inhibitor of the hypoxia-inducible factors (HIFs). These are a target of treatment based on […]

Alicia Morgans: Hi, my name is Alicia Morgans and I’m a GU medical oncologist and associate professor of medicine at Northwestern University in Chicago in United States. I’m so excited to have here with me today, a good friend and colleague, Dr. Silke Gillessen, who is a professor of oncology, as well as being the […]

Sam Chang: Hello everyone, my name is Sam Chang. I am urologic surgeon at Vanderbilt, but more importantly, we are today with Dr. Karim Chamie, associate professor. Well-deserving of full professorship, and I want to make sure that that gets passed on to his chair. He’s at UCLA, he’s going to give us actually some […]

(UroToday.com) The Society of Nuclear Medicine & Molecular Imaging (SNMMI) 2021 Annual Meeting included a session on FDA Radiopharmaceutical updates and a presentation by Drs. Shane Masters and Sue Jane Wang discussing clinical trial design and statistical considerations for PSMA PET drug development. Dr. Masters notes that “Guidances by the FDA” are the FDA’s current thinking […]

(UroToday.com) In a Satellite Symposium at the Society of Nuclear Medicine & Molecular Imaging (SNMMI) 2021 Annual Meeting, Dr. Phillip Koo, Dr. E. David Crawford and Dr. Steve E. Finkelstein discussed the practical applications and clinical utility of 18F-PSMA-targeted positron emission tomography (PET) imaging for urologists and radiation oncologists.

(UroToday.com) Advances in imaging have dramatically reshaped prostate cancer diagnosis, staging, and treatment. While multiparametric MRI (mpMRI) of the prostate has dramatically changed prostate cancer diagnosis, molecularly-targeted imaging has reshaped disease staging and detection of recurrent disease. Conventional imaging approaches using including computed tomography (CT) and bone scan have relatively limited sensitivity to detect disease recurrence […]

(UroToday.com) Advances in imaging have dramatically reshaped prostate cancer diagnosis, staging, and treatment. While multiparametric MRI (mpMRI) of the prostate has dramatically changed prostate cancer diagnosis, molecularly-targeted imaging has reshaped disease staging and detection of recurrent disease. Conventional imaging approaches using including computed tomography (CT) and bone scan have relatively limited sensitivity to detect disease recurrence […]

(UroToday.com) Beginning with the introduction of docetaxel for metastatic castration resistant prostate cancer (mCRPC) in 2004, there has been a dramatic and rapid proliferation of systemic therapy options in advanced prostate cancer including a number of novel hormonal therapies (including abiraterone acetate and enzalutamide), second-line chemotherapy (cabazitaxel), bone-targeting agents (radium-223) and other targeted agents (including olaparib, […]

A serendipitous cure in a 73-year-old woman of Hunner’s ulcer, urge, nocturia, apical prolapse by a tissue fixation system tensioned minisling (TFS) which reinforced the cardinal, and uterosacral ligaments (USLs) led us to analyse the relationship between Hunner’s ulcer and known pain conditions associated with USL laxity.

To evaluate the associations with interstitial cystitis during pregnancy using a United States inpatient database. We conducted a retrospective cohort study utilizing the Nationwide Inpatient Sample database from the Healthcare Cost and Utilization Project (HCUP-NIS).